Guide for authors  by unknown
Guide for Authors
1. Brief guidelines
FEBS Letters requires authors to submit all manuscripts
online. Manuscripts should be submitted at: http://febslet-
ters.manuscriptcentral.com/. Authors unable to submit online
should contact the editorial oﬃce at FEBS.Letters@urz.
uni-heidelberg.de.
• Please submit the text of your manuscript (including
title, keywords, abbreviations, main text, references and
ﬁgure legends) followed by tables and ﬁgures as a single
ﬁle.
• The ﬁle may be uploaded as .pdf, .doc, .ps or .rtf formats.
The manuscript should be given the name of the corre-
sponding author, e.g. Smith.pdf
• Standard fonts should be used. Times, Times New Roman or
Courier for the general text and Arial or Helvetica for the
ﬁgures.
• Use the Symbol font and the Insert Symbol option from
the menu bar for introducing symbols in MS Word.
• Figures should be prepared according to the detailed in-
structions given below (see ﬁgures).
• If you are unable to append your ﬁgures to the text docu-
ment, then upload the ﬁgures separately as .gif .jpg .eps .tiﬀ
.ppt or .xls ﬁles. These will be converted to small manage-
able .jpg ﬁles upon upload.
• Each ﬁgure should be labelled with a ﬁgure number.
• The length of the manuscript should not exceed 3000 words
(16 000 characters).
2. Editorial policy
FEBS Letters is an international journal established for the
rapid publication of short reports in the molecular biosciences.
It provides a forum for reviews and research reports that merit
urgent publication. FEBS Letters is published by Elsevier B.V.
on behalf of the Federation of European Biochemical Societies
(FEBS).
2.1. Aims and scope
Papers should be short but complete and essentially ﬁnal
reports. FEBS Letters is not a vehicle for the publication of
preliminary or fragmentary observations, for reports that are
scientiﬁcally sound but do not warrant urgent publication or
are only addressed to a specialized readership. As a rule, we do
not publish the following: cloning and sequencing of cDNA or
genes that have previously been reported for other species;
conventionally achieved expression of a protein; incomplete
NMR or other spectroscopic assignments; conventionally
achieved crystallization of a protein; correlative studies; or
negative observations. As a general policy, methodological
papers are not published unless they are truly novel and sig-
niﬁcant. In addition, papers applying standard bioinformatics
approaches to limited sets of publicly available protein or gene
sequences will only be considered if the results are of great
biological interest and are not easily obtained using readily
available methods. The overriding criterion is that a paper
must be of suﬃcient immediate importance to justify urgent
publication.
The subject area of FEBS Letters is broad. It covers bio-
chemistry (including protein chemistry, enzymology, nucleic
acid chemistry, metabolism, and immunochemistry), structural
biology, biophysics, computational biology (genomics, pro-
teomics, and bioinformatics), molecular genetics, molecular
biology, molecular cell biology (signal transduction, in-
tracellular traﬃc, regulation of cellular proliferation, cell–cell
interactions), and systems biology. Studies on microbes,
plants, and animals performed at the molecular level are within
the scope of FEBS Letters.
2.2. Submission of papers
All material submitted to FEBS Letters must be original and
not published or submitted for publication elsewhere. Closely
related papers that are in press or that have been submitted
elsewhere must be included with the manuscript.
We assume that all of the authors have approved the sub-
mitted manuscript. If this assumption turns out to be incorrect,
the manuscript will be withdrawn and will not be published.
Submission of a research letter implies that the authors are
willing to make available to academic researchers cell lines,
DNA clones, antibodies, or similar materials that have been
used in the experiments reported.
Data regarding protein or nucleic acid sequences and
structures solved by electron microscopy, nuclear magnetic
resonance or X-ray crystallography, should be deposited in
an appropriate, publicly available, database such as Gen-
bank, EMBL, SWISS-PROT, PDB, EMdep and BMRB.
Microarray data should be submitted to the GEO, CIBEX
or ArrayExpress databases in a format that complies with
MIAME guidelines. The databank must be in general use in
the ﬁeld and give free access to researchers. Database ac-
cession numbers should be listed in the manuscript and must
be obtained before the paper can be accepted for publica-
tion. For any data set for which there is no public re-
pository, data must be made freely available following
publication of the manuscript.
2.3. Evaluation of manuscripts
Initial evaluation of manuscripts takes place at the FEBS
Letters editorial oﬃce. Papers that pass this ﬁrst screen will be
assigned to an editor with experience in the ﬁeld who will
decide whether it should be sent out for peer review. All papers
published in FEBS Letters (Research Letters, Minireviews,
and Hypotheses) are peer-reviewed.
2.4. Language editing
Authors who are unsure of correct English usage should
have their manuscript checked by someone proﬁcient in the
language. Manuscripts in which the English is diﬃcult to un-
derstand may be returned to the author for revision before
scientiﬁc review. The following external services are oﬀered
here for your consideration only:
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International Science Editing Limited and Asia Science
Editing oﬀer a language and copyediting service to authors
who want to publish in scientiﬁc peer-reviewed journals. All of
their science editors are native English speakers and those
working for International Science Editing Limited also have
postgraduate qualiﬁcations and experience in science research.
For more information please see: http://www.internatio-
nalscienceediting.com/ or http://asiascieneediting.com/. With
Asia Science Editing, Elsevier has negotiated a rate of EUR
0.024 per word (ca EUR 6 per page). A EUR 10 handling fee
per manuscript is added, if payment is by credit card. Diﬀerent
rates apply for mathematic-based manuscripts. Turnaround
time is typically 5 days.
Authors in Japan: Upon request, Elsevier Science Japan will
provide authors with a list of people who can check and im-
prove the English of their paper (before submission). Please
contact our Tokyo oﬃce: Tel. +81 3 5561 5033; Fax: +81 3
5561 5047, E-mail: info@elsevier.co.jp
For all third party language editing recommendations, all
interaction and responsibility is between the Author and the
Language Editor. Language editing should not be confused
with the copy-editing that takes place during the production
process after a manuscript has been accepted.
2.5. Ethics of experimentation
Scientiﬁc investigations involving humans or animals must
have approval of the appropriate ethics committee. Animal
experiments should be carried out in accordance with the EU
(86./609/EEC) or the NIH guidelines. A statement that in-
formed consent was obtained from all subjects must accom-
pany investigations involving humans.
2.6. Colour reproduction
When essential to the understanding of a paper, ﬁgures may
be reproduced in colour (print and Web versions) at no cost to
the authors. The use of free colour is at the discretion of the
editorial oﬃce. Authors who wish to use colour (without the
approval of the editorial oﬃce) may do at no cost for the Web
version, but will be charged 340 (exclusive of sales tax) for a
single page printed in colour. For more than one full colour
page, the cost per page is 227 plus sales tax.
2.7. Copyright
Authors, or a third party, wishing to reproduce ﬁgures, ta-
bles, or brief quotations from the text of articles published in
FEBS Letters for non-commercial purposes may do so, pro-
vided that the original publication is acknowledged accord-
ingly and the authors’ approval is obtained. No special
permission is needed from FEBS, the Publisher, or the
Managing Editor for this. If authors, or a third party, wish to
use a major part of an article or an entire article elsewhere,
whether in English or any translation, permission must be
asked from the Publisher, who will, if necessary, contact
FEBS, the copyright holder.
2.8. Press releases
Authors who wish to issue a press release on material ac-
cepted by FEBS Letters are welcome to do so. The best time
for a press release is after completion of the typesetting of the
issue, i.e., usually about two weeks before the dispatch date.
Only then is the correct and complete reference known. The
initiative of a press release may be taken by the handling
editor, who will contact the authors and the editorial oﬃce.
3. Submission procedure
Please submit your manuscript through our online submis-
sion and peer-review system at: http://febsletters.manuscript-
central.com. Please prepare your text and ﬁgures according to
the manuscript preparation guidelines.
3.1. Original submissions
Authors are welcome to suggest one or two members of the
FEBS Letters Editorial Board whom they feel would be the
most appropriate to handle their manuscript. Please under-
stand that these requests cannot always be fulﬁlled. Authors
are also requested to provide the names and e-mail addresses
of 3–4 people who have the expertise to review their manu-
script. Authors may request that certain people – who are in
direct competition, or otherwise have a conﬂict of interest – be
excluded from the review process.
The editorial oﬃce will acknowledge receipt of your manu-
script within 24 hours of submission. Please contact the edi-
torial oﬃce (FEBS.Letters@urz.uni-heidelberg.de) if you do
not receive conﬁrmation within this period of time. The ‘date
of receipt’ that appears in the published paper will be the date
when the handling editor received the manuscript.
3.2. Revisions and resubmissions
3.2.1. Revisions
Papers may be returned to authors for revision. Authors will
be given four weeks after receipt of the reviewers’ comments to
revise their paper. Revisions must be submitted via the online
submission system, under the heading Submit a revised
manuscript. Click on the link Revised manuscripts then on
the View comments/Respond link to view the comments of
the editor and reviewers. Then click on the title of the manu-
script to upload your revised ﬁles. Please do not submit the
revision via e-mail.
3.2.2. Resubmissions
Papers may be rejected but the authors encouraged to re-
submit the paper after additional experimental data is ob-
tained. Resubmissions must be submitted via the online
submission system under submit ﬁrst draft of a new manu-
script. The paper must be marked as a resubmission and list
the handling editor and manuscript number of the original
submission. Please also provide a letter giving point-by-point
responses to the referees of the previous version.
4. Manuscript preparation guidelines
For the submission and peer-review process, FEBS Letters
urges you to prepare your manuscript as a single ﬁle using a
word processing programme and saving it as a .doc, .rtf, .ps or
.pdf ﬁle. When your paper is accepted for publication, you will
be asked to provide one complete copy of the paper containing
printers quality ﬁgures and a CD with the most recent version
of the text and ﬁgures to the editorial oﬃce.
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4.1. Research letters
General arrangement – The length of the submitted manu-
script should not exceed 16 000 characters or 3000 words, in-
cluding the ﬁgure legends and tables. Editors will accept longer
papers only when there are compelling reasons to do so. Any
repetition of information in the text and ﬁgures should be
avoided.
The text should be double-spaced and size 11 or larger and a
standard font (Times, Times New Roman, Arial, or Helvetica)
should be used. When using Word, insert all symbols by se-
lecting Insert-Symbol from the menu and use the Symbol
font.
The title page of the manuscript should be followed by
numbered sections:
1. Introduction
2. Materials and methods
3. Results
4. Discussion
5. Acknowledgements
6. References
7. Figure legends
8. Tables and ﬁgures
When appropriate, results and discussion sections may be
combined.
4.1.1. Title page
The ﬁrst page of the manuscript should contain the follow-
ing information:
Title
The title should be a maximum of two printed lines in the
journal (140 characters, including spaces). Active titles are
preferred. Technical terms, such as ‘cloning,’ ‘expression,’
‘puriﬁcation’ and specialized abbreviations should be avoided.
Titles should not be repetitive but clearly and concisely state
the subject of the manuscript. FEBS Letters reserves the right
to edit titles for length and clarity.
Authors’ names and aﬃliations
The full names and aﬃliations should be provided for all
authors. The corresponding author should also provide a full
postal address, telephone and fax number (including country
code), and an e-mail address as a footnote on the title page.
Abstract
The abstract should be less than 100 words in length and
summarize the question being addressed and the pertinent
ﬁndings.
Keywords
The keywords should reﬂect the signiﬁcant factors of the
investigation as a whole. Authors are requested to consult
the annual cumulative subject index of FEBS Letters or the
list of subject headings from Index Medicus. A maximum of
six keywords should be selected and included with the
submitted manuscript. The list submitted may be amended
to ensure that index entries are consistent in the master
index. General terms such as enzyme or membrane should
not be used unless qualiﬁed, e.g. membrane translocation,
enzyme activation.
List of abbreviations
Authors should follow internationally agreed rules as set out
in Biochemical Nomenclature and Related Documents (A
Compendium, 2nd edition, 1992) International Union of
Biochemistry and Molecular Biology, published by Portland
Press, London and Chapel Hill, UK. Abbreviations should be
expanded in a footnote on the title page.
4.1.2. References
These should be numbered in square brackets, e.g. [7], or
[11–13,17], in order of citation in the text. The list of references
will be printed at the end of the paper. References to data-
bases, personal communications or unpublished data should
be cited in the text or as footnotes. Articles may only be cited
as ’in press’ if a copy of the acceptance notice is supplied at the
time of submission. References should include the title of the
article and be cited as follows:
Examples of journals [1,2] and books [3,4]:
[1] MacKinnon, R. (2003) Potassium channels. FEBS Lett. 555, 62–65.
Table 1
Line art: Halftones: Combination artwork:
Charts, graphs and hand-drawn
images
Photographic images, micrographs artwork with both, text/lines and
photographic images (e.g. gels with
lanes labelled)
Text Use standard fonts or embed all
fonts
N/A Use standard fonts or embed all
fonts; use solid black or white text
Colour encoding RGB RGB RGB
Compression Colour – none Black & White –
LZW
Colour – none Black & White –
LZW
Colour – none Black & White –
LZW
Save as .eps (recommended) or .tiﬀ
(1000 dpi)*
.tiﬀ (300 dpi) .eps (recommended), or .tiﬀ
(500 dpi)*
*Use .tiﬀ format for scanned images or when it is not possible to save in .eps format.
Note. While an image may look perfect on the screen, it is often of insuﬃcient resolution for publication. Try viewing your ﬁgure at 400% on the
screen, if it is not blurry, it is probably of high enough resolution for the printing process.
Glossary:
RGB – (red, green, blue) colour mode.
LZW – type of compression recommended for black and white images.
Dpi – (dots per inch) measure of resolution for printers, scanners and displays.
EPS – (Encapsulated PostScript) ﬁles are the preferred format for electronic line art and combination art (not for Corel Draw, see below).
.tiﬀ – (Tagged Image File Format) is the recommended ﬁle format for scanned halftones, bitmaps and colour images: Corel Draw ﬁles should be
saved in .tiﬀ format using a minimum resolution of 500 dpi.
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[2] Nixon, J.E., Wang, A., Morrison, H.G., McArthur, A.G., Sogin,
M.L., Loftus, B.J. and Samuelson, J. (2002) A splicesomal intron in
Giardia lamblia. Proc. Natl. Acad. Sci. USA 99, 422-431.
[3] Langer, T. and Neupert, W. (1994) Chaperoning mitochondrial
biogenesis, in: The Biology of Heat Shock Proteins and Molecular
Chaperones (Morimoto, R.I., Tissie`res, A. and Georgopoulos, C.,
Eds), pp. 53-83. Cold Spring Harbor Laboratory Press, Plainview,
NY.
[4] Feldmann, H. (2004) Forty years of FEBS. Blackwell Publishing
Ltd., Oxford.
4.1.3. Tables
Tables should be used only when the data cannot be pre-
sented clearly in the text. Authors are requested to consult
recent issues of FEBS Letters for the proper table layout. The
heading of the table should make its general meaning under-
standable without reference to the text.
4.1.4. Figures
Use quality graphic programmes such as Adobe PhotoShop,
Adobe Illustrator, Corel Draw, or Freehand to create your
ﬁgures. Figures should be approximately the same size as you
would like them to appear in press. Please prepare and save
your ﬁgures according to Table 1.
While we strongly encourage you to save your ﬁgures as .tiﬀ
or .eps ﬁles, the following format types are also acceptable,
provided you follow Elsevier’s instructions (http://authors.
elsevier.com/artwork); Word (.doc), Excel (.xls) or PowerPoint
(.ppt), Adobe PDF, Adobe Illustrator (.ai) or PhotoShop
(.psd).
4.1.5. DNA sequence accession numbers
For every accession number cited in an article, authors
should type the accession number in bold, underlined text.
Letters in the accession number should always be capitalized.
This combination of letters and format will enable the type-
setters to recognize the relevant texts as accession numbers and
add the required link to GenBank’s sequences. Example:
GenBank accession nos. AI631510, AI631511, AI632198, and
BF223228. Please check accession numbers used very carefully
as an error in a letter or number can result in a dead link.
4.1.6. Supplementary material
Authors are requested to include sequence, microarray, and
other supporting data as supplementary data. Figures and text
should be prepared according to the above guidelines and
should be provided at the time of initial submission.
Movies/animations – Supplementary movies or animation
ﬁles should be provided in one of the following formats: .mpg,
.mov, .gif, and .avi. For more information please see: http://
authors.elsevier.com/artwork.
4.2. Minireviews and Hypotheses
The Minireviews and Hypotheses should be topical and of
interest not only to specialists in the ﬁeld but also to the
general reader. Suﬃcient information should be included in the
introduction to provide background to non-specialists. Mini-
reviews should not be longer than 2500 words, and preferably
not have more than 50 references and three ﬁgures or tables.
They should contain at least one ﬁgure, scheme, or table that
illustrates a central aspect of the review. A short abstract (less
than 100 words) and 3–6 keywords should be included. The
author(s) should use short descriptive subtitles. Papers labelled
Hypothesis’ should present novel ideas or new interpretations
of established observations, but should be based on sound data
and avoid excessive speculation (please note that preliminary
experiments cannot be published as a Hypothesis).
Since the majority of Minireviews and Hypotheses are soli-
cited, authors who wish to submit such manuscripts should
e-mail the FEBS Letters Editorial Oﬃce (FEBS.Letters@
urz.uni-heidelberg.de) prior to submission, providing a title,
abstract and key references of the article to be considered.
5. Publication matters
For general enquiries and answers to frequently asked
questions, please visit Author Gateway at http://authors.else-
vier.com. The Author Gateway also provides the facility to
track accepted articles and set up e-mail alerts to inform you
when an article’s status has changed, as well as detailed art-
work guidelines and copyright information.
Please address all queries concerning accepted manuscripts
to FEBS Letters Issue Management. E-mail: FEBSLettersI-
M@elsevier.com, specifying the manuscript number and
handling editor.
5.1. Proofs
The corresponding author will receive proofs by e-mail
(PDF proofs). Authors are requested to check the proofs and
return any corrections within 48 hours. Thereafter, proofs will
be processed and included in the ﬁrst available issue. Late
corrections cannot be accepted. If the authors wish to in-
troduce extensive changes (at the issue manager’s discretion)
the proofs will be sent to the handling editor and be treated as
a revised version. Amendments requiring this extra procedure
at the proof stage may delay the publication of the paper by
several weeks.
5.2. Reprints
Upon acceptance of a paper the corresponding author will
receive a form where reprints of that article may be ordered,
including the 50 free reprints. Queries concerning reprints
should be addressed to: authorsupport@elsevier.com. Please
mention in the subject line reprints and your manuscript
number.
Copyright  1996-2004, Federation of European Biochem-
ical Societies. All rights reserved.
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